These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22410027)
1. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma. Choi HJ; Kim DG; Na GH; Hong TH; You YK Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027 [TBL] [Abstract][Full Text] [Related]
2. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Wai CT; Woon WA; Tan YM; Lee KH; Tan KC Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028 [TBL] [Abstract][Full Text] [Related]
4. Living donor liver transplantation for hepatocellular carcinoma. Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251 [TBL] [Abstract][Full Text] [Related]
5. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Ito T; Takada Y; Ueda M; Haga H; Maetani Y; Oike F; Ogawa K; Sakamoto S; Ogura Y; Egawa H; Tanaka K; Uemoto S Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766 [TBL] [Abstract][Full Text] [Related]
6. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival. Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053 [TBL] [Abstract][Full Text] [Related]
7. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852 [TBL] [Abstract][Full Text] [Related]
8. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma. de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614 [TBL] [Abstract][Full Text] [Related]
9. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559 [TBL] [Abstract][Full Text] [Related]
10. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471 [TBL] [Abstract][Full Text] [Related]
12. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623 [TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113 [TBL] [Abstract][Full Text] [Related]
14. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Lee KW; Yi NJ; Suh KS Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825 [TBL] [Abstract][Full Text] [Related]
15. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma. Na GH; Kim EY; Hong TH; You YK; Kim DG HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857 [TBL] [Abstract][Full Text] [Related]
16. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma. Decaens T; Roudot-Thoraval F; Badran H; Wolf P; Durand F; Adam R; Boillot O; Vanlemmens C; Gugenheim J; Dharancy S; Bernard PH; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Hilleret MN; Chazouillères O; Cherqui D; Mallat A; Duvoux C Liver Int; 2011 Jul; 31(6):792-801. PubMed ID: 21645209 [TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023 [TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Takada Y; Ito T; Ueda M; Sakamoto S; Haga H; Maetani Y; Ogawa K; Ogura Y; Oike F; Egawa H; Uemoto S Dig Dis; 2007; 25(4):299-302. PubMed ID: 17960063 [TBL] [Abstract][Full Text] [Related]
20. HCC in living donor liver transplantation: can we expand the Milan criteria? Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]